Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
No. 1 Fertility is a leading Australian reproductive health group specializing in advanced fertility treatments and assisted reproductive technology. Founded by renowned fertility specialist Dr. Lynn Burmeister, the company operates several state-of-the-art clinics and laboratories across Victoria. Their service portfolio includes in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), egg freezing, and comprehensive donor programs. The organization is particularly noted for its expertise in managing complex cases such as endometriosis, polycystic ovary syndrome, and recurrent pregnancy loss. By integrating cutting-edge genetic testing with personalized clinical protocols, No. 1 Fertility aims to optimize success rates for patients seeking to build families. The company also operates a dedicated egg bank to support diverse reproductive needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on No. 1 Fertility.